Clinical Trials Directory

Trials / Completed

CompletedNCT01626768

Medtronic Market-Released DF4 Lead Imaging

Status
Completed
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The Medtronic Market-Released DF4 Lead Imaging Study is a prospective, non-randomized study, multi-center clinical investigation. The purpose of this clinical investigation is to collect high quality medical images of the Medtronic Market-Released DF4 lead in the shoulder and heart. Images collected during the study will allow for lead design and testing processes better tailored to the implanted environment.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-06-25
Last updated
2013-07-17

Locations

2 sites across 2 countries: Saudi Arabia, United Kingdom

Source: ClinicalTrials.gov record NCT01626768. Inclusion in this directory is not an endorsement.

Medtronic Market-Released DF4 Lead Imaging (NCT01626768) · Clinical Trials Directory